350
Russ.Chem.Bull., Int.Ed., Vol. 60, No. 2, February, 2011
Dorokhov et al.
2JC,F ≈ 22.0); 126.9, 132.5 and 133.4 (all д, С , 4JC,F ≈ 3.0);
СН ); 8.08 (s, 1 Н, Н(4)); 7.10—7.90 (m, 2 Ph of both tautoꢀ
i
2
3
13
1
1
1
29.2, 131.2 (br.s) and 131.4 (all d, С , J
≈ 9.0); 136.6 and
mers). C NMR (CDCl ), δ: enol form: 53.0 (OMe); 88.1 (=СН);
o
C,F
3
37.8 (C(4) and С(5)); 140.3 (С(3)); 155.2 (С(6)); 163.0 (COO);
63.1, 164.7, and 166.0 (all d, С , J = 248—254); 179.2
126.1 (С(4)); 126.7, 128.2, 128.3, and 129.1 (С and С ); 129.7
o
m
and 130.8 (C ); 134.8 and 137.8 (C ); 140.5 (С(5)); 143.0 (С(3));
p
C,F
p
i
(
1
1
(
1
=COH); 190.5 (C=O); ketone form: 44.4 (CH ); 53.7 (OMe);
156.1 (С(6)); 163.6 (COO); 179.8 (=COH); ketone form: 44.4
2
2
15.8, 116.1, and 116.4 (all d, С , J
≈ 20); 132.4, 133.2, and
(CH ); 53.1 (OMe); 127.7 (С(4)); 126.8, 128.6, 128.9, and 129.3
m
C,F
2
4
34.2 (all d, С , J
≈ 2.9 Hz); 131.0, 131.2 (br.s) and 131.5
(С and С ); 130.7 and 133.4 (C ); 133.3 and 136.2 (C ); 141.9
i
C,F
o
m
p
i
3
all d, С , J
≈ 9.0 Hz); 136.7 and 138.2 (C(4) and С(5));
C,F
(С(5)); 150.8 (С(3)); 158.8 (С(6)); 164.5 (COO); 194.5 (C=O);
o
13
47.2 (С(3)); 156.9 (С(6)); 163.0, 164.5 and 166.1 (all d, Сp,
C NMR (DMSOꢀd ), δ: enol form: 53.2 (OMe); 87.6 (=СН);
6
J
= 248—254 Hz); 164.5 (COO); 190.6 and 194.0 (C=O).
126.1 (С(4)); 126.7, 128.9, 129.0 and 129.6 (С and С ); 130.2
o m
and 131.4 (C ); 134.6 and 137.6 (C ); 140.4 (С(5)); 144.0 (С(3));
p i
156.2 (С(6)); 163.3 (COO); 179.0 (=COH); ketone form: 44.6
C,F
9
1
F NMR (282 MHz, CDCl ): enol form: –103.6, –109.0, and
3
3
4
–
110.7 (all tt, 1 F each, J
≈ 8.7 Hz, J
≈ 5.5 Hz); ketone
H,F
H,F
3
form: –103.5, –104.2, and –111.3 (all tt, 1 F each, J
≈ 8.7 Hz,
(CH ); 53.4 (OMe); 127.9 (С(4)); 128.5, 128.8, 129.2, and 129.3
H,F
2
4
JH,F ≈ 5.5 Hz).
(С and С ); 129.6 and 134.0 (C ); 135.6 and 136.5 (C ); 141.6
o
m
p
i
Methyl 4ꢀ(4ꢀbromobenzoyl)ꢀ6ꢀ(4ꢀbromobenzoyl)methylꢀ5ꢀ(4ꢀ
bromophenyl)pyridazineꢀ3ꢀcarboxylate (5e). A mixture of pyridꢀ
azines 5e and 6e in the molar ratio 5 : 1 was obtained from
(С(5)); 150.8 (С(3)); 159.4 (С(6)); 164.5 (COO); 196.8 (C=O).
Reaction of methyl diazoacetate with 4ꢀfluorophenacylpyriꢀ
dinium bromide in an aqueous solution. A solution of methyl diazoꢀ
acetate (1.56 g, 9 mmol) in acetonitrile (2 mL) was added to
a solution of 4ꢀfluorophenacylpyridinium bromide (1.33 g,
4.5 mmol) in water (18 mL), and potassium carbonate (1.56 g,
9 mmol) containing 20% water was added. The reaction mixture
was stirred for 15 h at 20 °С, then extracted with ethyl acetate
4
ꢀbromophenacylpyridinium bromide (1.07 g, 3 mmol) and meꢀ
thyl diazoacetate (0.10 g, 1 mmol) (see Table 3). Recrystalliꢀ
zation from methanol gave 0.36 g (54%) of pyridazine 5e,
m.p. 214—216 °С. Found (%): C, 47.89; H, 2.67; N, 4.48.
C H Br N O . Calculated (%): C, 48.18; H, 2.55; N, 4.16.
2
7
17
3
2
4
1
H NMR (CDCl ), δ: enol form (88%): 3.90 (с, 3 Н, ОМе); 5.67
s, 1 Н, =СН); 7.00 (br.d, 2 Н, 2 Н , J = 8.2 Hz); 7.32—7.58
m, 2 C H and 2 Н ); 15.9 (br.s, 1 Н, ОН); ketone form (12%):
(3×20 mL), and dried with anhydrous MgSO . The solvents were
3
4
3
(
(
removed in vacuo, the solid residue was washed with methanol
(2 mL) at 0 °С, and 0.50 g of a mixture of pyridazines 5d and 6d
m
6
4
o
1
13
3
.98 (s, 3 Н, ОМе); 4.63 (s, 2 Н, СН ); 6.91 (br.d, 2 Н, 2 Н ,
were obtained, which were analyzed by Н and С NMR specꢀ
troscopy (the total yield and the ratio of pyridazines 5d and 6d
are given in Table 3). Then double recrystallization from chloroꢀ
form gave orangeꢀyellow crystals enriched in trisubstituted pyridꢀ
azine 6d to ~65%. Methyl 6ꢀ(4ꢀfluorobenzoyl)methylꢀ5ꢀ(4ꢀ
fluorophenyl)pyridazineꢀ3ꢀcarboxylate (6d) was identified by the
2
m
3
13
J = 8.2 Hz); 7.32—7.58 (m, 2 C H4 and 2 Н ). C NMR
6
o
(
CDCl ), δ: enol form: 53.5 (OMe); 88.9 (=СН); 124.3, 126.1,
3
and 129.4 (С ); 128.4, 130.0, 130.7 (br.s); 131.8, 132.1, and 132.3
p
(
С and С ); 129.8, 134.9, and 135.8 (С ); 136.4 and 137.7 (C(4)
o
m
i
and С(5)); 140.6 (С(6)); 156.4 (С(3)); 163.1 (COO); 178.4
=COH); 190.8 (C=O); ketone form: 44.4 (CH ); 53.7 (OMe);
1
13
(
H and C NMR spectra by subtracting the signals of the deꢀ
2
1
1
1
24.4, 126.2, and 129.6 (С ); 128.4, 129.8, 130.1, 130.7 (br.s);
scribed above pyridazine 5d. H NMR (CDCl ), δ: enol form
p
3
31.9 and 132.4 (С and С ); 130.2, 134.7, and 135.7 (С ); 136.2
(88%): 4.03 (s, 3 Н, ОМе); 6.01 (s, 1 Н, =СН); 7.00—7.29
(m, 6 Н, 4 H and 2 H ); 7.48 and 7.77 (both dd, 2 Н each, 4 H ,
o
m
i
and 137.5 (C(4) and С(5)); 145.0 (С(3)); 159.4 (С(6)); 163.3
m
p
o
(
COO); 190.7 and 193.0 (C=O).
JH,H = 8.9 Hz, JH,F = 5.6 Hz); 7.67 (s, 1 Н, Н(4)); 16.2 (ОН);
Methyl 6ꢀbenzoylmethylꢀ5ꢀphenylpyridazineꢀ3ꢀcarboxylate
6c). A solution of methyl diazoacetate (0.50 g, 5 mmol) in acetoꢀ
ketone form (12%): 4.08 (s, 3 Н, ОМе); 4.77 (s, 2 Н, СН );
2
(
7.00—7.31 (m, 6 Н, 4 Hm and 2 H ); 7.56 and 7.95 (both dd,
p
nitrile (11 mL) was added to a solution of phenacylpyridinium
bromide (4.17 g, 15 mmol) in water (100 mL), and potassium
carbonate (6.90 g, 50 mmol) containing 20% water was added by
portions of 1—1.5 g with stirring, waiting for the complete dissoꢀ
lution of each portion. The reaction mixture was stirred for 15 h
at 20 °С, extracted with ethyl acetate (3×50 mL), and dried with
2 Н each, 4 H , J
Н(4)). C NMR (CDCl ), δ: enol form: 53.3 (OMe); 87.3
(=СН); 115.5 and 116.5 (both d, С , J
(C(4)); 129.1 and 130.3 (both d, С , J
= 8.8 Hz, JH,F = 5.5 Hz); 8.08 (s, 1 Н,
o
H,H
1
3
3
2
≈ 21.5 Hz); 126.2
m
3
C,F
= 8.6 Hz); 131.7 and
C,F
o
4
133.2 (both d, С , J
≈ 3.0 Hz); 139.9 С(5)); 142.5 (С(3));
i
C,F
155.3 (С(6)); 163.5 (COO); 163.6 and 166.1 (both d, С , J
=
p
C,F
anhydrous MgSO . The solvents were removed in vacuo, the
= 250—254 Hz); 180.2 (=COH); ketone form: 44.3 (CH ); 53.6
4
2
2
solid residue was treated with hot methanol (15 mL), and cooled,
and an orange finely crystalline precipitate was filtered off. The
filtrate was evaporated to half a volume and cooled to –5 °С and
the precipitate formed was joined with the previous portion of
(OMe); 115.8 and 116.2 (both d, С , JC,F ≈ 21 Hz); 128.0
m
4
(С(4)); 133.2 and 134.2 (both d, С , J
≈ 3.0 Hz); 130.8 and
i
C,F
3
131.6 (both d, С , J
≈ 9.0 Hz); 138.2 С(5)); 147.2 (С(3));
o
C,F
158.8 (С(6)); 164.5 and 166.1 (both d, С , J
≈ 250 Hz); 164.5
C,F
p
1
19
the precipitate. The obtained product was analyzed by Н and
(COO); 194.3 (C=O). F NMR (282 MHz, CDCl ): enol form:
3
13
3
4
С NMR spectroscopy (the total yield and the ratio of pyridꢀ
–109.6 and –110.9 (both tt, 1 F each, J ≈ 8.7 Hz, J ≈ 5.5 Hz);
H,F H,F
3
azines 5c and 6c are given in Table 3). Then trisubstituted pyridꢀ
azine 6c was isolated as yellow crystals by double recrystallizaꢀ
tion from chloroform, m.p. 149—151 °С. Found (%): C, 72.64;
H, 4.91; N, 8.20. C20H16N O . Calculated (%): C, 72.28;
ketone form: –104.6 and –111.8 (both tt, 1 F each, J
≈ 8.6 Hz,
H,F
4
JH,F ≈ 5.5 Hz).
Reaction of methyl diazoacetate with 4ꢀbromophenacylꢀ
pyridinium bromide in an aqueous solution. Similarly to the previꢀ
ous experiment, the reaction of 4ꢀbromophenacylpyridinium broꢀ
mide (1.07 g, 3 mmol) and methyl diazoacetate (0.10 g, 1 mmol)
2
3
+
+
H, 4.85; N, 8.43. MS, m/z (I (%)): 332 [M] (3), 255 [М – Ph]
5), 227 [M – COPh]+ (10), 195 (7), 167 (15), 105 (100).
H NMR (CDCl ), δ: enol form (84%): 4.02 (s, 3 Н, ОМе); 6.16
rel
(
1
in an H O—MeCN mixture (14 mL, 9 : 1) afforded 0.61 g of
3
2
(
s, 1 Н, =СН); 7.73 (s, 1 Н, Н(4)); 7.37—7.55 (m, 2 Ph of both
a mixture of pyridazines 5e and 6e, which were analyzed using
the Н and С NMR spectra (the total yield and the ratio of
1
13
tautomers); 7.74 (d, 2 H, J = 7.9 Hz, H of one of Ph); 16.2
o
(
ОН); ketone form (16%): 4.09 (s, 3 Н, ОМе); 4.81 (s, 2 Н,
pyridazines 5e and 6e are listed in Table 3). Methyl 6ꢀ(4ꢀbromoꢀ